Transitioning to The Digital ILC 2020: 27–29 August, 100% digital
Given the continuing impact of the SARS-CoV-2 pandemic and resulting restrictions, EASL has decided to transition the onsite International Liver Congress™ 2020, planned for 25–28 August, to an immersive and exciting digital event - The Digital International Liver Congress™ 2020,…
From the epicentre of Italy’s pandemic: Take care and keep steady
Prof. Luca Valenti, Associate Professor of Internal Medicine, University of Milan, describes fighting the pandemic from its epicentre in Milan
EASL-ESCMID Position Paper: Patients with advanced liver disease and transplant recipients require specific care during COVID-19
The European Association for the Study of the Liver (EASL) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) have issued a Position Paper, providing recommendations for clinicians caring for patients with liver diseases during the current pandemic…
BioMed Alliance submits Joint Statement to EU leaders, as COVID-19 threatens medical associations
Subsequent to the disruption caused by the COVID-19 pandemic, EASL and 32 other leading European medical associations – together forming the Biomedical Alliance in Europe (BioMed Alliance) – have submitted a joint statement to EU leaders. Together, we are calling…
EASL postpones ILC 2020 until August
13 March 2020 Given the ongoing developments with COVID-19, EASL has postponed the International Liver CongressTM (ILC 2020) that was scheduled for 15-19 April 2020 in London. Having reviewed the situation, and after taking extensive advice, we have decided on…
Experts discuss latest research and future of liver cancer
Over 600 delegates from 44 countries gathered in Prague at the EASL Liver Cancer Summit 2020 to discuss latest developments and the future of liver cancer research. Organised annually by EASL, the European Association for the Study of the Liver,…